ASEAN: Market for Medicaments Containing Corticosteroid Hormones 2024

Market Size for Medicaments Containing Corticosteroid Hormones in ASEAN

The ASEAN medicaments containing corticosteroid hormones market totaled $X in 2022, increasing by X% against the previous year. The total consumption indicated a buoyant increase from 2012 to 2022: its value increased at an average annual rate of X% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, consumption increased by X% against 2015 indices. The level of consumption peaked in 2022 and is expected to retain growth in the near future.

Production of Medicaments Containing Corticosteroid Hormones in ASEAN

In value terms, medicaments containing corticosteroid hormones production declined slightly to $X in 2022 estimated in export price. In general, production saw a mild shrinkage. The pace of growth was the most pronounced in 2015 with an increase of X% against the previous year. As a result, production reached the peak level of $X. From 2016 to 2022, production growth remained at a lower figure.

Exports of Medicaments Containing Corticosteroid Hormones

Exports in ASEAN

In 2022, overseas shipments of medicaments containing corticosteroid hormones increased by X% to X tons, rising for the second consecutive year after two years of decline. In general, exports, however, recorded a perceptible slump. The pace of growth was the most pronounced in 2014 with an increase of X% against the previous year. As a result, the exports reached the peak of X tons. From 2015 to 2022, the growth of the exports remained at a lower figure.

In value terms, medicaments containing corticosteroid hormones exports soared to $X in 2022. Over the period under review, exports recorded tangible growth. The growth pace was the most rapid in 2014 when exports increased by X% against the previous year. As a result, the exports attained the peak of $X. From 2015 to 2022, the growth of the exports remained at a somewhat lower figure.

Exports by Country

In 2022, Indonesia (X tons) was the key exporter of medicaments containing corticosteroid hormones, achieving X% of total exports. It was distantly followed by Singapore (X tons), Thailand (X tons) and Malaysia (X tons), together committing a X% share of total exports.

Exports from Indonesia decreased at an average annual rate of X% from 2012 to 2022. At the same time, Singapore (X%) and Thailand (X%) displayed positive paces of growth. Moreover, Singapore emerged as the fastest-growing exporter exported in ASEAN, with a CAGR of X% from 2012-2022. By contrast, Malaysia (X%) illustrated a downward trend over the same period. From 2012 to 2022, the share of Singapore and Thailand increased by X and X percentage points, respectively. The shares of the other countries remained relatively stable throughout the analyzed period.

In value terms, Singapore ($X) remains the largest medicaments containing corticosteroid hormones supplier in ASEAN, comprising X% of total exports. The second position in the ranking was held by Indonesia ($X), with a X% share of total exports. It was followed by Malaysia, with a X% share.

In Singapore, medicaments containing corticosteroid hormones exports increased at an average annual rate of X% over the period from 2012-2022. In the other countries, the average annual rates were as follows: Indonesia (X% per year) and Malaysia (X% per year).

Export Prices by Country

The export price in ASEAN stood at $X per ton in 2022, standing approx. at the previous year. Over the period under review, the export price, however, recorded a buoyant increase. The most prominent rate of growth was recorded in 2014 when the export price increased by X%. Over the period under review, the export prices hit record highs at $X per ton in 2020; however, from 2021 to 2022, the export prices failed to regain momentum.

Prices varied noticeably by country of origin: amid the top suppliers, the country with the highest price was Singapore ($X per ton), while Thailand ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Singapore (X%), while the other leaders experienced a decline in the export price figures.

Imports of Medicaments Containing Corticosteroid Hormones

Imports in ASEAN

In 2022, imports of medicaments containing corticosteroid hormones in ASEAN soared to X tons, rising by X% against the previous year's figure. Over the period under review, imports showed a strong expansion. The pace of growth appeared the most rapid in 2017 with an increase of X%. Over the period under review, imports hit record highs in 2022 and are likely to see steady growth in the near future.

In value terms, medicaments containing corticosteroid hormones imports soared to $X in 2022. Overall, imports posted a buoyant expansion. The pace of growth appeared the most rapid in 2015 with an increase of X%. Over the period under review, imports hit record highs in 2022 and are expected to retain growth in years to come.

Imports by Country

In 2022, Malaysia (X tons) was the major importer of medicaments containing corticosteroid hormones, creating X% of total imports. Thailand (X tons) took a X% share (based on physical terms) of total imports, which put it in second place, followed by Vietnam (X%), the Philippines (X%), Myanmar (X%), Indonesia (X%) and Singapore (X%).

From 2012 to 2022, average annual rates of growth with regard to medicaments containing corticosteroid hormones imports into Malaysia stood at X%. At the same time, Myanmar (X%), Singapore (X%), Vietnam (X%), the Philippines (X%) and Thailand (X%) displayed positive paces of growth. Moreover, Myanmar emerged as the fastest-growing importer imported in ASEAN, with a CAGR of X% from 2012-2022. By contrast, Indonesia (X%) illustrated a downward trend over the same period. From 2012 to 2022, the share of Malaysia, Myanmar, Vietnam and Singapore increased by X, X, X and X percentage points, respectively.

In value terms, the largest medicaments containing corticosteroid hormones importing markets in ASEAN were Vietnam ($X), Thailand ($X) and Singapore ($X), together comprising X% of total imports. The Philippines, Malaysia, Indonesia and Myanmar lagged somewhat behind, together comprising a further X%.

Among the main importing countries, Myanmar, with a CAGR of X%, saw the highest rates of growth with regard to the value of imports, over the period under review, while purchases for the other leaders experienced more modest paces of growth.

Import Prices by Country

The import price in ASEAN stood at $X per ton in 2022, declining by X% against the previous year. Import price indicated a measured expansion from 2012 to 2022: its price increased at an average annual rate of X% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, medicaments containing corticosteroid hormones import price decreased by X% against 2019 indices. The pace of growth appeared the most rapid in 2018 when the import price increased by X%. The level of import peaked at $X per ton in 2019; however, from 2020 to 2022, import prices stood at a somewhat lower figure.

There were significant differences in the average prices amongst the major importing countries. In 2022, amid the top importers, the country with the highest price was Singapore ($X per ton), while Myanmar ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Indonesia (X%), while the other leaders experienced more modest paces of growth.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :